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There are two distinct lincages of T cells: T -ccll 
reccptor (TCR) O'{3-bearing cells (0'{3 T cclls) and TCR 
I'D-bearing cells (I'D T cells). All of the 0'{3 T cells and 
most subsets of I'D T cells dcvclop in thc thymus. It 
has been dcm.onstratcd that the protein tyrosinc 
phosphatase CD45 plays a pivotal role in the intra-
thymic developrnent of 0'{3 T cells. Thymocytc mat-
uration is arrested at thc transitional stage fronl 
immature CD4+ CD8+ double-positive to maturc 
CD4+ or CD8+ single-positive cells after CD45 exon 
6 gene disruption. In this study, wc examincd 
whether Vy3 dcndritic epidcrmal T cells (DETC), a 
subset of thymus-dcpendent 1'0 T cells uniquely re-
siding in the murine epidermis, arc altered in the 
CD45 exon 6-dcficient mice. [II sitll itnmunolabeling 
on epidermal sheets dcmonstrated that the CD45-
deficient Inicc had a nornlal dcnsity and imlnunophe-
T he re arc t w o eli sti llCt lin eages o f T ce ll s: (I'{3 T-ce ll recepror (TC ll..)-hea rin g cells (u{3 T ce lls) ,mel )'8 T C lt- he arin g ce ll s ( ),e) T ce ll s). T he ove rwh e lmin g maj o rity o fel endritic e pide rmal T cell s (D ETC) in rhe l11urin e skin be lon g to rh e )'!) T - cell lin e age and 
express T C ll.. cO lllp osed o f V)':\ . j )' 1. C)' I / V !) I. \)c)2 • .J 82. CIl 
chains (Asarn o w l' / al. I <) 8<) . Alth o ug h it is kll o wn that V)'J D ETC 
p recursor ari ses in th e th ymus. th e d e ve lopmental sta ges t har V )'J 
I) ETC undergo re main un c lear (Tigelaar and Lewis. IY95) . T he 
C D 45 m o lecule is th o ught to be illipo rt:mt for the deve lo plll cnt of 
cx{3 T ce ll s. hut rh e role of C I) 4 .:; in )'8 T -ce ll dcvelo pm e n t is less 
c lea r. 
C I)'+ 5 is ;1 rr;lIlSln e11lbrane pro le in ryros in e ph os ph atase (PT l'asc ) 
expressed 011 a ll nucl ea ted hcnla ro po ietic ce ll s ann th e ir precursors 
(Th o ma s. IYW». C I).J 5 m o le c ule pla ys a pivo ral rol e in T-ce ll 
d eve lo pme11( (Trowbridge and Th o mas. IY94) . T-cell matura tion 
in t h e th ymu s in vo lves :1 selen io l1 m echanism w he re by ce rrain cells 
s LlI'v iv e wh e re as o the rs arc destroyed. The se lectio n processes 
p l·eser ve the d eve lo pin g T ce ll s tha t ex prcss se lt:'m ,uor hi stocom-
patibiliry complex-res tri c te d , fu re ig n ;111tigen-spec ific TC R s (pos-
itive sel ec tion) and e liminate allto rea c rive cells (n egari\'e select io n). 
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notypc of Vy3 DETC compared with the w ild-type 
controlnlice . Reversc transcriptasc polyme rasc chain 
reaction r evealed that similar lev els of Vy3 TCR 
mRNA were prescnt in thc cpidermis of CD45-defi-
cient mice and wiJd-ty pe controls . F low cytomctry 
dcmonstrated no significant difference in the propor-
tion of Vy3 T cclls in the epidcrmis betwce n the 
genotypcs. In addition , Vy2 T c e lls , another subset of 
1'0 T cells, were also cxamined by flow c y tomet ry. 
The frcqucncy of Vy2 T cclls in lymph nodes w a s 
norm.al in the CD45-de ficient mice . Our r e sults indi-
cate that although CD45 is crucial for the dcvelop-
ment of 0'{3 T cclls, this molccule is not neccssary for 
the thymic maturation of y{) T cells, includin g Vy3 
DETC and Vy2 T c clls. Key "'O/'ds: t}".osille phosphatase! 
gelle kllockollt/mice/Tlry-1+ cell.] [rlllest DcrmatoI108:49-
52, 1997 
Alrh o u!!;h ir is w e ll kn o wn thar positive and nega ri ve sekerio n 
process~s arc cruc ial in the Shapin g of the C\'f3 T-ce ll re pe rro ire. rhc 
ro le o f sel ectio n in rhe !!;e ne ra ri o n o f )'() T cell s re m ains un clea r. 
C D.J 5 has heen demon~rrarcd to pb y an impo rtant ro le in th e 
transiti o nal st,lge of C D.+ + C D 8 + do uble-pos iti ve to CD .J + or 
C D 8 + sin g k - positi ve th ),m ocyres in rh e ma turat io n of Cl'{3 T cells 
(Kishih ara ("/ (/1. 11)9:\) . In rhis srudy. we in vestigated rh e role o r 
CD ·~ 5 in the deve lo pment o f )'D T ce lls II sin g C D 45-ddicie ll t mi ce. 
In partic nlar . w e examined V)'3 DETC :1 n d TCR V)'2 + ce ll s in 
C D.+ 5-dctic ient mice b y ill .< i/II inll1111n o phello typin g . tl nw cyro m-
e rry. and reverse tran scripl:! se pol ),11le rase chain rcactio n . 
MATERI ALS AN I) METHO DS 
Mice C I) .15 gCl1 e-ta rgL' led tnll1 :1 111 (knockoul ) nl ice (- / - mice) were 
kindl ), slIl'l'lied hy Dr. T. \'(/. Mak (A tnge ll Illsti lll le. Un iversiry n(Tornnto. 
C anada ) and w crc I1l'11l1ta ill cd u\1d e r a ~pcc i fic p ;lt h og:e ll - fr ee cl1\' iro l1l11 c IH 
:11 the animal colo l1 )' (S lInn yhmnk Hea lth Sciel1 ce Cenrer. Ulliversity of 
To ro ll to) . ~rh l' knockout mice w ere g-c ll erilt cd h y ge 11 t: d is ru ptio ll nf CD-1 5 
L'XO Il () and hac k-crossed 111 0 1"e 111 :1 11 fi\'t: d l1l L' S u) C57 13L/ 6, as descrihed 
pre" ioll sly (Kishihara ('( Ill. 199.1). CS7BL/ (, 111icl' wcre purchased fmlll the 
C harles R i\·L'r I3n..'L'c.iill g La hora ro ri L" (Quehec. Ca ll :lda) and \Ve re lI "'ed as ;) 
wild- Iypl' cOlll m l ( /+ lI,in·). All IIli cc wnc' li SCO at K- 12 wk of age . 
Antibodies MOII ,)c lo llal alllihodics (MoA hs) . illclud illg all t i-V)'~ TCR. 
-V)'2 TCit. -)'0 Te R. alll i-V)'.l TC IU liu Cl rcscein isnrhiocyan:1ll' (FITC). 
all ti-rrJ3 TC R/ FITC. al1li- T hy- I.2/ phycoerythri ll . all o :1l1 l i-CD .l~ /CJ) 16 
(10 hl ock Fc)'R II / III ) . and i",r),l'e cOlHrols were purchased Ii-olll I'ha nl1 -
il1 gc l1 (Sail Diego. CA). Allli-CD.1. -CD.J. - DH. anri- T hy- I.:!. alld all li-
C D3/ I'E were pttrchasl'o ti'llm SCnJle.- (Torn ill O. ON). SC'co lldary :lIlti hod-
il' !' , including ~oa[ anti- rat I ~G / bi ntill. goat' :lIHi - h a lll S(Cl" IgG / h in till . and 
1I022-2t1 2X / 97/ SltI .5 () • COl'yri ght l ' 1')97 hy T he Socie ,-y (') 1' II\\'estigarivc Ik nl1 orology. 111 <'. 
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Figure 1. A normal number of Vy3 TCR + cells is 
present in the epidermis of CD4S-deficiel1t l11ice. 
Epidermal sheets obtained fro lll C D45-d cfic ienr mice and 
the wild-type mice we re immul1 0 labeled with M o Abs 
against C D4 5 and Vy3 T C R" C D4 S+ ce ll s were absen t ill 
tbe epidermis of C D45 - 1- mice (n) . whereas C D45 + 
ce ll s were prese llt in the wild-type contro ls (I» , A three-
step labe lin g procedure with anti-V y3 T C R revea led no 
signifi cant d iffe rence in the density of Vy3 + ce ll s be-
tween C D4 5 - 1- mice (r) and +1+ mice (d) (I' > 0,05), 
Although the staining was weaker by direct labeling, 
sillli lar lIumbers of labeled ce ll s were see II in both geno-
types (e ,f) , Senl .. bnr. 50 I.un , 
strepta vidin / FITC, were purchased fi'om CcdarJane Laboratories (Hornhy, 
O N) , Goat anti- m o use IgM / biotin and ExtraAvidin /TRITC were pur-
chased fro m Sigma (St. LOllis, M O). 
[" Si(II Imlnlll1o\abeling Epidermal sheets were o btain ed (i'om th e ca rs 
of llli ce b y a separating technique usin g 0.5 M ammo nium thiocyanate or I'Y., 
dispasl! (Matsu <: eI (I I. 1992: Ki lgus ('( nl , 1993). ACl!tonl!- ftx l!d epidermal 
, Iwe ts w ere I" bekd with a three-step jJTlJ11ullo labc li ng procedure. as 
described previo usly (Wang e ( nl. 1992). I3ri cfl y. ep idennal slwets were first 
ill cuhared w ith M oA bs overnig ht at 1'00111 tempe ra ture . tbl!n washl!d with 
pho'l'ha[c-bullc red saline and reacted with a bio tin-conju g;lted Sl!conda ry 
antibod y at 37"C for 1 h . Afte r washing with phosphate-buffe red s,IIill e. the 
epid <: rm,II sheets we re incubatl!d w ith strep tavidin /FIT C at 3 7°C for I h. 
Alternatively. epidermal sheets were directly labeled w ith al1ti-Vy3 TC R I 
FITC ovemight at roo l11 te J11peratun! . Pos iri vc labeled dendril.ic e pidcl'lw,r 
ce lls w c.re coun ted in te ll rand0 l11 field s w ith the a id of a rni c rOlllctcr grid . 
For dO li hi e iJ11l11unolabeling, epidermal sheets w ere in cubated with MoAbs 
(e .g., anti-CD3) as described ea rli er , thell reacted w ith biotin-conjugated 
seconda ry antibodies :lIId visuali zed by ExtrA vidin / TRJT . alld lil1a ll y 
douh le labe led with a l1 ti-Vy3 T c rUFIT c. 
F low Cytometry Epidermal shee ts o btailled (i'om the Cars and trull k skill 
were trea ted w ith 0 .1 'X, trypsin alld 0.025')/" DNase fo r I 0 min at 37°C. 
Epiderlll al cell suspensions were prepared and ill cubated overnigh t in the 
presl!nce of recombinant humall interkukin-2 (20 U per ml) to allow the 
recovery ofT C R. ex press io ll (Correa ('/ nl. 1992). T he ce ll suspensions we re 
then subjected to a 15-l11in de nsity g rad ient centrifugation o n L)'tlI-
pho lyte-M (Cedarlall e Labo ratories) . L)'l11ph node cell sll spensio ns we re 
prl!pared fi'o lll the in guina l and axillary lymp h nodes . as descl'ihed prl!v i-
o ll sl)' (Wang o ( nl, 1996). Ce ll s (10") we re incubated for 5 m in 0 11 ice with 
anti-C D321CD I6 to bloc k FcyR /l / fll, then rcactl!d will. allti -Vy3 TCR / 
FITC (fo r l!pidcrlllal cl! lI s) o r with anti-Vy2 T C R /F IT C (for I)'mph Il odl! 
cdls) for 45 min o n icc. After waShing, the ce ll s Wl!rl! reactl!d w ith 
aIlC;-T hy- I .2/PE o r all ti-CD3/PE for ano ther 45 min 0 11 iel!. Two-colo r 
inllnl1 ll oflu o resce ll ce was alla lyzed 0 11 " C oulw r EPI CS 75L !low cy to 'T, e!' l! r 
(Hialeah. FL) . A minimum of 20,O()() cd ls were analyzed fo r l!<fell sam) l!!. 
THE J OU I~NAL OF INVESTIGATIVE DER,MATOLOC}, 
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Reverse Trallscriptase-Polymerase Chain Reaction O ligo llucleo, 
t,des we re synthes ized b)' I)alron C hemical Lahoratories )n c. (North Yo rk ' 
ON, C an:rda). Prime rs fo r TCn. V y3 \Ve re : 5' -TGT GCA CGT GTA CC, 
ACT GA-Y (sense) and 5'-CAG AGG GAA TT A C TA TGA GC- 3' 
(a nti-sense) (Erb (./ "I. 1995). Prin1.,..S fo r /3-actill WCre: S' - GTG GGC CGQ 
T C T AGG C AC C AA-3 ' (sense) and 5' - CT C TTT GAT GTC ACG CAQ 
GAT TTC-3' (allti-sense). Total RNA was ex tractl!d from ep i,krn);,1 cell 
suspensio n. and (i'om thYl1lus and live r as contro ls (Cho lll czYllski antI 
Sacchi, 1987): e DNA sYllthl!sis and 'rrnpli f' catio ll Wl!re thell pe rfo rlll e<\ 
(Kolldo (./ nl. 1993) . 
R ESULTS 
Density ofVy3 TCR+ Cells Is Normal ill the Epidermis 0 1) 
CD45-Deficient Mice The defi c ie n cy of' C D4S m o lecules w as 
conf,rme d b y ill sit" iml11uno labe ling w ith allti-C 0 45 M oA b Oil the 
e pide rm al sheets fi 'om C D 45-defic ient mice. C D45 + d e ndritic ce ll s 
were absent in the epide rmi s ofC 045 -/ - mice (Fig 1(/), wh e reas 
num e rous C D45 + d e ndriti c ce ll s . re prese nting DETC and Lang-
e l'hans cell s, wcre presen t in th e e pidermis of wild-ty pe mi ce (Fig 
Ib). E pide rm'll sh ee ts stained w ith <lnti-Vy3 T C R b y a rhree - st ep 
labe lin g procedure d e m onstrate d a pop ula t ion of V -y3 T C R + cells 
with hig hl y dendritic m o rpho logy present in both C045 - /- mice 
(Fig lc) and CD45 +1+ mice (Fig ttl) . T h e re was no s ignifi ca n t 
ditferen ce in the d e n sity of V y3 TCR + ce ll s be tw een tI'l! C1)45-
ddi c ic n t mi ce and th e w ild-type mi ce (4 '17 :!: 52 cell s/m n / ' s 
4 23 :!: 4 1 ce liS/111m2 • 'nean :!:: SO; p > (l.O S). 
Epide rmal sb eets sta in e d direc tly with anti-V-y3 TC R /F IT C 
dem o n strate d V -y3 TCR + cell s in bo th ge n otypes; h owever. 
labe ling wa s weaker than th e sta inin g with th e three- ste p proce-
dure . and th e ce ll s appeared less dendritic. N everth e less. th e 
numbe r o f V -y3 TCP.. + cell s pre se nt in t h e C 0 45-d eficienl' mice 
(Fig lc) was similar to tha t in the w ild- type mice (Fig 1./) . 
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Figurc 2. F low cytolllctric analysis de monstrates a n ormal propor-
tion of V1'3 DETC in the epidermal cells of CD45-deflcient mice. 
Ep idcrmal cell suspell sio ns obta illed (i'om CD45-dcticie llt mice and the 
\vild- typc J11i ce \ve re doubl e iU1IlH IIl o iabc lcd ,·vith a llti- T hy-I .2 / PE 1) (' r S II S 
anti-V y3 TCR/FITC (n,h) or anri-cr {3 TCR/ FITC (co lltro l) (r,d). as de-
sc ri bed ill M(/fcr;n/s ,.,"'/ }\fethuds. Ce ll suspe ll sio ns were anal yzed hy two-
color How cytomctry. A m in imum of 21l,UOO ce lls we re allal yzed for c:tch 
sampl e 0 11 a Co ulter EPI CS 75L Row cytom e ter. A silllil ;1r proportion or 
T h y-I +/Vy3 TCIt + douh le-positive ce ll s (DETC) e" isted in the wi ld-type 
m ic e (0'1) and in CD45-deficiclll: Illi ce (h) . 
Phenotypic Characterization of V1'3 TCll..+ Cells l)h eno-
typic ana lys is of Vy3 TCR .. + ce ll s wi th double il11muno labeling 
de m o nstrated that these ce Us were CD3 +, CD4 - . CD8 - , T hy-
1 + , and yo TC R + in both CD45-deficient mi ce ;1I1d w il d-rype 
mice, confirming tha t they were DETC. CD45 molecul e was also 
expressed o n Vy3 TCR + ce ll s in the w ild- type con trols. but not in 
CD45-def-icien t mi ce. 
Abundant TCR Vy3 Transcripts Are Present in CD45-
Deficient Micc To in vestigate w hether the ex pressio n of TCR 
Vy3 mRNA was norm al in the CD45-deficient mice. we per-
formed reverse transcrip tase-polym era se chain reaction . Abu nd ant 
TCR V 1'3 transcripts were de tected in the epidermis fi'0111 both 
CD45 - I - mi ce and + I + mi ce. but !lot in the li ve r o r thymus. N o 
sig nifi ca n t diffe rence in the level ofTCR. Vy3 I1lRN A was detected 
between th e genotypes. 
Proportion of V1'3 DETC in Epidcrmal Cells Is Normal in 
CD45-Dcficicnt Mice To determine the percentage of V')'3 
DETC among the epiderm al cell s, we detected T hy- I and Vy3 
TCR do ubl e-positive ce lls by two-co lo r Row cyto l11etry . To re-
move the dead cells and debris. epidermal cell suspensio ns were 
grad ien t cen tl'ifuged 0 11 Iympho lyte-M befo re im1l1l1n o labeling . As 
sh own in Fig 2, epidermal cell suspensio ns fi'o m CD45-defic ient 
mice con ta in ed norm al proportions of Vy3 TCR + IThy- '1 + dOll -
ble- positive ce ll s (D ETC) as com pa red w ith the wild- type mi ce . 
Vy2 T Cclls Dcvelop Normally in CD45-Dcficicl1t Mice To 
examin e w hether CD45 molecul es affect othe r subsets of yiS T ce ll s. 
w e de tected V1'2 T ce ll s by two-co lo r Row cytom etry in the lymph 
nodes fi'om CD45-deflcie n t mi ce. Abou t 1.2-2.3'1., of lymph node 
cell s were V y2 TCR .. + ICD3+ dou ble-positive cells ill both CD45 
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- I - mice and the + I + mi ce . N o significant d iffe rence in the 
fi' equency of Vy2 T cells was detected between these genotypes. 
DlSCUSS[ON 
[n 1983, in vestigators demo11strated that ill additio n to Langerhans 
ce ll s, the murine epidermi s harbors a population ofThy-] + , m ajor 
hi stocompatibili ty com plex cla ss 11 - dendriti c cells (Bel'gstresser {'I 
(/1, 1983; TschachJer e/ (/1, '1983). These ce lls wel'e initially termed 
T hy-1 + dendritic ep idermal cells (Thy-1 + DEC). With the dem-
onstratio n that T hy-1 + DEC express TCn... these cells have been 
identified as a subset of T -cell lineage and renamed dendl'itic 
epiderm al T cells (DETC) (Stingl {'I (/1. J 987; Steiner et aI, 1988). 
Further studies demonstrated that the majority of DETC bear an 
iden tica l TCR, com posed of V')'3 . J ,),l , Cy1 IV 01, D02, J 02. CD 
gene segm ents (Asarnow l'f aI, 1989) . T he e xact fu nction of these 
V 1'3 DETC remain s uncl ear. 
V ')'3 DETC develop in the feta l thymus. Earl y fetal thymocytes 
express the sa1l1e TCR V ')'3 , J y1. CyllV ,51 , D02, .1 02, Co as 
DETC. Furth ermo re, the disappearance of V ')'3 TCR + thymocytes 
directl y precedes the first appearance of V 1'3 DETC in the epider-
mis, suggesting that they repl'esen t the precursor cells of DETC 
(Havran and Allison, 1988). Further evidence ha s been o btained 
fi'om the observat ion that Vy3 DETC are absen t in the epidermi s of 
athY1l1ic nu / nu mi ce. T ranspl anta tion of fe tal thymus o r injection of 
feta l thym ocytes in to yo un g nu / nu mice or congenic adult mice 
resu lts in th e appeara nce of donor- type DETC in the epidermis of 
recip ients (l-lavran and Allison, 1990; Payer ('/ aI, 199 1). 
R esearch shows tha t a{3 T cells and yo T cell s are prod ucts of 
separate lin eages that arise fi'o m common progenitors; the lineages 
segregate before the onset ofTCR gene rearran gements (Bass and 
Tonegawa, 1992) . The a{3 cell lin eage and yo ce ll lin eage ma y 
d iverge at a stage just before the expression ofCD4 and CD8 in the 
a{3 ce ll lin eage (Petrie ef aI, 1992) . T he ontogenesis of a{3 T ce lls is 
clea r: a{3 T cells deve lop from double-negative CD4 - C D8 -
TCR - immature cells in the thymus. then progress to a double-
positi ve CP4 -J- CD8 + TCR I"", stage . I~in a ll y they undergo a 
selection process, and becom e mature sin gle-positive CD4 + 
TCRhi);h or CD8 + TCRhi"h T cells (Shortman , 1992). T he on to-
genesis of yo T cell s, how e ver, rem ain s unclear. Altho ugh a small 
number of yo TC R.. + thymocytes express CD8 and even low levels 
o f CD4, the development of ')'0 ce ll s does not in vo lve a CD4 + 
CD8 + double-positi ve stage ([tohara c/ al. 1989; Fisher and 
Cered ig. 199 1) . 
CD45 is one of the most abundan t leukocyte cell surface glyco-
proteins. CD45 is a PTPase and plays important roles in lymph ocyte 
activa tion and thymic maturation . An tigen receptor- in duced signal 
transdu ction in both T -cell and B-cell lines is crucially dependent 
o n the transmem brane PT Pase. Mod ulation of CD45 isoform 
expressio n may be involved in thymic selection events (Wal lace c( 
aI, 1992). To in vestigate the ;/1 I, i llO role ofCD45 in the dev elo p-
ment of lymphocytes. [{jshihara ('/ al (1993) generated CD45-
deficient mi ce by gene disruption of CD45 exon 6. These mutant 
mice lacked CD45 e"'Pressio n on 13 cells and on the majority of 
thY1l1ocytes and peri pheral T cells. In these mi ce. B lymphocytes 
develop no rmall y. but T -Iymph ocyte development is impa ired. 
T hym ocyte m atura tion is blocked at the tran sitio nal stage fi'om 
imma tu re doubl e-positi ve CD4 + CD8 + to 1l1a ture single- positive 
CD4 + or CD8 + cell s. and thus the nu mber ofpe l"ipheral T cells is 
dram atica lly decreased. T hese o bservations suggest that CD45 
PT Pase plays a crucial role in the development of a{3 T cells. 
W hether CD45 PTPase also plays a .-ole in the developm e nt of 
')'0 T ce lls rcmaillS unclear. R .. ecentiy, Kawa i ct at (1995) reported 
that the development of Vy3 DETC was impaired in CD45 
PTPase-deficien t (exon 6 gene- ta rgeted) mice as w e ll as in p56lck 
prote in ty rosin e k..inase-deticient mice. Both protein tyr osine ki -
n<lses and PTPases pla y im portant ro les in signa l transduction during 
thym ocyte development, but they ac t at different ti111 es. U nl ike the 
late block il1 thymocyte development in CD45-dcficien t 111.ice. the 
block in p56kk -defi cient mice occurs at an early stage (betore 
positive and nega tive selection processes begin) (Molin a I'f (/1, 
52 WANG /;..,. I lL 
1992). Further studies demonstrate that the thymi c development of 
tran sgenic yo T cells is greatly impai red ill pS(,I"k-deficiePt mice 
(Penninger ct ai, 11)')3). ThereFo re, it is not surpri sing that the 
matL;ratioll of both 0'(3 cells and yo ce lls is impaired aFter p56 kk 
ge ne disruption. We were surprised, how ever, by the I'inding tha t 
CD45 affected the development of yo T ce ll s. 
In contrast to the tinding of Kawai 1'1 al (1995), o ur study 
de mo nstrated no significant diffe rences in the density, J11ol-phology, 
or phenotype of Vy3 DETC between CD45 - j - mi ce and 
wi ld- type mi ce. The discrepancy between the groups may be 
re lated to the ex perim ental protoco l. In oLir stud y for direct 
immunos ta ining, we in cubated the epiderma l sheets with FITC -
conjugated anti-Vy3 TCR MoAb overn ight at room remperahll'c, 
whel"cas Kawai el at incubated the sheers fo r on ly I h at 37°C . The 
staining ofVy3 DETC was weaker and the dendri tic processes were 
less obv iolls with the direct immunolabeling techn iqu e th;1I1 with 
indirectimmullolabding. Nevertheless, a similar llumber of Vy3 + 
dendritic ce lls were found in the cpidermis ill CD4S-deficient mi ce 
and in the wi ld-type mice. When the epidermal sheets were 
immllno labe led by " three-step procedurl', the Vy3 DETC w ere 
labe led more inte nsel y and the dendrites we re more apparent, as 
ex pected. To examine further whether th ese aJ) ti-Vy3 TCR-
reactive cells w ere DETC, we perform ed double labeling. Pheno-
typica ll y, a ll of the VyJ TCR+ cells were C D3+ , CD4 - , CD8 - , 
yo TCP. .. + , and Thy-1 +, confinning that they were DETC. To 
eva.lua te the proportion of Vy3 DETC in the tota l cpiderma l cell s, 
we performed Row cytometric an" l y~ i s on epidermal ce ll Sllspen-
sion. T he result reve'll ed th;lt the percentage ofVy3 DETC alllong 
epidermal ce ll s was similar in C D4S-deficicnt mice and the wi ld-
typc mice. 
To investigate whether CD45 dcticien cy affects the maturation 
of o th er subsets of y8 T cell s besides V)'3 IJ ETC, we esamined Vy2 
T cell s by Row cy tometry. Vy2 T cell s represent anoth er subset of 
y8 T cells loca ted lJlainl y in the secondary lymphoid organs. We 
found that there was no signifi ca nt difterence in the proportion of 
Vy2 T cell s in the lymph node cell s between CD45 - j - mi ce and 
the + /+ mice. 
Taken together, oLir observations demonstr<lte that the di sruption 
of CD45 exon 6 does not block the devel opment of Vy3 DETC or 
Vy2 T cell s, suggesting that CD45 PTPase is not necessary for the 
development of yo T cells. 
1~/c IiMII/' Dr . . /",,/, Il f/. M(/I<;;,,./,ill"/), pro"it/illg liS ",ith Ihe C D45 ex,," fi - / -
III;rl". /lVe nrl' "/.<,, grat,:!i" to Ms . V. Sachs for her expert (,,,./,,,ie,,/ (/SS iSlall fC ;11 j7m/! 
cyltlJ}u'lry and /0 !\I/s. D. Bar/Oil alii/ J\lIs. C. Plircell .Ii,,. their Itdp ;11 brcct/ill,f: th e 
"",( ,.",( ,,,;rl<. T I,i.< "'eld, /IIns SIII'I'" ,.I,," b)' (he Medical Reseaccic C elllllcil (/\lIRe) '!( 
C /IIltlr/o (/lid the C a/l ndiol1 [)('nllo(olo,(!), FOlil/dnriol/. 
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